Semiconductors Healthcare Sector

Varex Imaging

Market Cap: US$311.3m

Designs, manufactures, and sells X-ray imaging components.

Septerna

Market Cap: US$310.7m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Entrada Therapeutics

Market Cap: US$306.7m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Fulcrum Therapeutics

Market Cap: US$306.6m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

National Research

Market Cap: US$306.2m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Healwell AI

Market Cap: CA$426.3m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

Outset Medical

Market Cap: US$305.1m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Mayne Pharma Group

Market Cap: AU$465.5m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Anbio Biotechnology

Market Cap: US$299.3m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

XOMA Royalty

Market Cap: US$296.3m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

aTyr Pharma

Market Cap: US$294.1m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Imricor Medical Systems

Market Cap: AU$448.8m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Atai Life Sciences

Market Cap: US$287.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Aquestive Therapeutics

Market Cap: US$283.1m

Operates as a pharmaceutical company in the United States and internationally.

American Oncology Network

Market Cap: US$282.0m

Through its subsidiaries, provides oncology management services in the United States.

Aurora Cannabis

Market Cap: CA$393.5m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Heron Therapeutics

Market Cap: US$280.7m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Oceania Healthcare

Market Cap: NZ$470.7m

Owns and operates various care centers and retirement villages in New Zealand.

Compass Therapeutics

Market Cap: US$276.6m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Quantum-Si

Market Cap: US$276.5m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Corvus Pharmaceuticals

Market Cap: US$276.3m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Abeona Therapeutics

Market Cap: US$273.2m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

EBR Systems

Market Cap: AU$421.3m

Develops implantable systems for wireless tissue stimulation.

Neuronetics

Market Cap: US$272.5m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Viemed Healthcare

Market Cap: US$272.3m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Cartesian Therapeutics

Market Cap: US$271.0m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Jade Biosciences

Market Cap: US$269.6m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Aura Biosciences

Market Cap: US$268.9m

A clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors.

Humacyte

Market Cap: US$268.4m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

2seventy bio

Market Cap: US$266.1m

A cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States.

iTeos Therapeutics

Market Cap: US$264.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

Immutep

Market Cap: AU$408.9m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Tristel

Market Cap: UK£198.0m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

SANUWAVE Health

Market Cap: US$261.2m

Operates as a medical device company in the United States and internationally.

Verano Holdings

Market Cap: CA$363.3m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Cerus

Market Cap: US$258.1m

Operates as a biomedical products company.